Turkiye Klinikleri Journal of Dermatology

.: REVIEW
Coffee and Skin: What do We Know About it?
Kahve ve Deri: Hakkında Ne Biliyoruz?
Ahu YORULMAZa
aClinic of Dermatology, Ankara Numune Training and Research Hospital, Ankara, TURKEY
Turkiye Klinikleri J Dermatol. 2019;29(1):31-5
doi: 10.5336/dermato.2019-66044
Article Language: EN
Full Text
ABSTRACT
 Coffee is one of the world's most popular drinks. It is only an inspirational morning refreshment for some, but for others it has become a lifestyle beverage with a global consumption of billions cups per day. Because of its popularity, coffee has often been proposed to be able to prevent health problems and has attracted a great deal of research over the years. Although there has been limited research evaluating the effectiveness of coffee in ameliorating certain health conditions, there is a compelling evidence that coffee consumption has potential benefits for a variety of chronic diseases. Recent studies have confirmed that moderate amount of coffee consumption might have a role in protection against type 2 diabetes, metabolic syndrome, Parkinson's disease, Alzheimer's disease, depression, cognitive impairment, chronic liver disease, chronic kidney disease, prostate cancer, endometrial cancer, liver cancer, leukemia and cardiovascular diseases, including hypertension, coronary heart disease and venous thromboembolism. In dermatological point of view, currently there is a growing body of evidence suggesting that caffeine and other nutrients contained in coffee may protect against melanoma and non-melanoma skin cancer. Moreover, as the new data on coffee and health continues to get emerged, it is getting clear that coffee is also effective in inflammatory disease prevention, including inflammatory skin diseases. In this review, we focused on recent evidence about coffee and dermatological diseases and aimed to explore the link between coffee and melanoma/ non-melanoma skin cancers, psoriasis and rosacea.

Keywords: Coffee; melanoma; non-melanoma skin cancer; psoriasis; rosacea
ÖZET
 Kahve dünyada en fazla tüketilen içecekler arasında yer alır. Kahve bazıları için sadece bir sabah uyaranı olabilir, ancak bazıları içinse günlük global tüketimi milyarlarla ölçülen bir hayat tarzı içeceğidir. Popularitesi nedeniyle, kahvenin sıklıkla sağlık problemlerini önlediği ileri sürülmüş ve kahve yıllar içerisinde çok sayıda araştırmanın başlıca konularından biri olmuştur. Her ne kadar, kahvenin bazı hastalıkları iyileştirmesindeki etkinliği ile ilgili ortaya konmuş yeterli veri yoksa da, günümüzde kahvenin çok sayıda kronik hastalığın önlenmesinde faydalı olduğunu gösteren kayda değer veriler bulunmaktadır. Son yıllarda yapılan çalışmalar, makul düzeyde kahve tüketiminin tip 2 diyabet, metabolik sendrom, Parkinson hastalığı, Alzheimer hastalığı, depresyon, kognitif bozukluklar, kronik karaciğer hastalığı, kronik böbrek hastalığı, prostat kanseri, endometrium kanseri, karaciğer kanseri, lösemi ve hipertansiyon, koroner arter hastalığı ve venöz tromboembolizmi de içeren kardiyovasküler hastalıklara karşı koruyucu rol oynayabileceğini göstermiştir. Dermatolojik açıdansa, kahvede bulunan kafein ve diğer bileşenlerin melanoma ve melanom dışı deri kanserlerine karşı koruyucu olduğunu gösteren veriler gün geçtikçe artmaktadır. Dahası, kahve ve sağlıkla ilgili yeni veriler ortaya çıktıkça, kahvenin inflamatuar deri hastalıkları da dahil olmak üzere, inflamatuar hastalıkların önlenmesinde etkili olduğu daha anlaşılır düzeye ulaşmış bulunmaktadır. Bu derlemede, kahve ve deri hastalıkları ile ilgili güncel literatüre odaklandık ve kahve ile melanom, melanom dışı deri kanseri, psöriazis ve rozaseanın ilişkisini irdelemeyi hedefledik.

Anahtar Kelimeler: Kahve; melanom; melanom dışı deri kanseri; psöriazis; rozasea
REFERENCES:
  1. Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J. Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ. 2017;359:j5024. [Crossref]
  2. Whayne TF Jr. Coffee: a selected overview of beneficial or harmful effects on the cardiovascular system? Curr Vasc Pharmacol. 2015;13(5):63748. [Crossref]
  3. Fredholm BB. Notes on the history of caffeine use. Handb Exp Pharmacol. 2011;1(200):1-9. [Crossref] [PubMed]
  4. Loftfield E, Freedman ND, Dodd KW, Vogtmann E, Xiao Q, Sinha R, et al. Coffee drinking is widespread in the United States, but usual intake varies by key demographicand lifestyle factors. J Nutr. 2016;146(9):1762-8. [Crossref] [PubMed] [PMC]
  5. Weisse AB. Coffee: grounds for concern? Proc (Bayl Univ Med Cent). 2015;28(1):122-3. [Crossref]
  6. Bae JH, Park JH, Im SS, Song DK. Coffee and health. Integr Med Res. 2014;3(4):189-91. [Crossref] [PubMed] [PMC]
  7. Grosso G, Godos J, Galvano F, Giovannucci EL. Coffee, caffeine, and health outcomes: an umbrella review. Annu Rev Nutr. 2017;37:131-56. [Crossref] [PubMed]
  8. Cano-Marquina A, Tarín JJ, Cano A. The impact of coffee on health. Maturitas. 2013;75(1):7-21. [Crossref] [PubMed]
  9. Nieber K. The impact of coffee on health. Planta Med. 2017;83(16):1256-63. [Crossref] [PubMed]
  10. Alicandro G, Tavani A, La Vecchia C. Coffee and cancer risk: a summary overview. Eur J Cancer Prev. 2017;26(5):424-32. [Crossref] [PubMed]
  11. Temple JL, Bernard C, Lipshultz SE, Czachor JD, Westphal JA, Mestre MA. The safety of ingested caffeine: a comprehensive review. Front Psychiatry. 2017;8(1):80. [Crossref] [PubMed] [PMC]
  12. Franco R, Oñatibia-Astibia A, Martínez-Pinilla E. Health benefits of methylxanthines in cacao and chocolate. Nutrients. 2013;5(10):4159-73. [Crossref] [PubMed] [PMC]
  13. Spaeth AM, Goel N, Dinges DF. Cumulative neurobehavioral and physiological effects of chronic caffeine intake: individual differences and implications for the use of caffeinated energy products. Nutr Rev. 2014;72 Suppl 1:34-47. [Crossref]
  14. Caini S, Cattaruzza MS, Bendinelli B, Tosti G, Masala G, Gnagnarella P, et al. Coffee, tea and caffeine intake and the risk of non-melanoma skin cancer: a review of the literature and meta-analysis. Eur J Nutr. 2017;56(1):1-12. [Crossref] [PubMed]
  15. Wu S, Han J, Song F, Cho E, Gao X, Hunter DJ, et al. Caffeine intake, coffee consumption, and risk of cutaneous malignant melanoma. Epidemi ology. 2015;26(6):898-908. [Crossref] [PubMed] [PMC]
  16. Lukic M, Jareid M, Weiderpass E, Braaten T. Coffee consumption and the risk of malignant melanoma in the Norwegian Women and Cancer (NOWAC) Study. BMC Cancer. 2016;16:562. [Crossref] [PubMed] [PMC]
  17. Conney AH, Lu YP, Lou YR, Kawasumi M, Nghiem P. Mechanisms of caffeine-induced inhibition of UVB carcinogenesis. Front Oncol. 2013;3:144. [Crossref] [PubMed] [PMC]
  18. Loftfield E, Freedman ND, Graubard BI, Hollenbeck AR, Shebl FM, Mayne ST, et al. Coffee drinking and cutaneous melanoma risk in the NIHAARP diet and health study. J Natl Cancer Inst. 2015;107(2). [Crossref]
  19. Liu J, Shen B, Shi M, Cai J. Higher caffeinated coffee intake is associated with reduced malignant melanoma risk: a meta-analysis study. PLoS One. 2016;11(1):e0147056. [Crossref]
  20. Ferrucci LM, Cartmel B, Molinaro AM, Leffell DJ, Bale AE, Mayne ST. Tea, coffee, and caffeine and early-onset basal cell carcinoma in a case-control study. Eur J Cancer Prev. 2014;23(4):296-302. [Crossref] [PubMed] [PMC]
  21. Song F, Qureshi AA, Han J. Increased caffeine intake is associated with reduced risk of basal cell carcinoma of the skin. Cancer Res. 2012;72(13):3282-9. [Crossref] [PubMed]
  22. Oh CC, Jin A, Yuan JM, Koh WP. Coffee, tea, caffeine, and risk of non-melanoma skin cancer in a Chinese population: The Singapore Chinese Health Study. J Am Acad Dermatol. 2019 Feb 4. [Epub ahead of print]. [Crossref]
  23. Micek A, Godos J, Lafranconi A, Marranzano M, Pajak A. Caffeinated and decaffeinated coffee consumption and melanoma risk: a dose-response meta-analysis of prospective cohort studies. Int J Food Sci Nutr. 2018;69(4):417-26. [Crossref] [PubMed]
  24. Wang J, Li X, Zhang D. Coffee consumption and the risk of cutaneous melanoma: a meta-analysis. Eur J Nutr. 2016;55(4):1317-29. [Crossref] [PubMed]
  25. Vaseghi G, Haghjoo-Javanmard S, Naderi J, Eshraghi A, Mahdavi M, Mansourian M. Coffee consumption and risk of nonmelanoma skin cancer: a dose-response meta-analysis. Eur J Cancer Prev. 2018;27(2):164-70. [Crossref] [PubMed]
  26. Fortes C, Mastroeni S, Boffetta P, Antonelli G, Pilla MA, Bottà G, et al. The protective effect of coffee consumption on cutaneous melanoma risk and the role of GSTM1 and GSTT1 polymorphisms. Cancer Causes Control. 2013;24(10):1779-87. [Crossref] [PubMed]
  27. Kang NJ, Lee KW, Shin BJ, Jung SK, Hwang MK, Bode AM, et al. Caffeic acid, a phenolic phytochemical in coffee, directly inhibits Fyn kinase ac tivity and UVB-induced COX-2 expression. Carcinogenesis. 2009;30(2):321-30. [Crossref] [PubMed] [PMC]
  28. Wang Y, Ho CT. Polyphenolic chemistry of tea and coffee: a century of progress. J Agric Food Chem. 2009;57(18):8109-14. [Crossref] [PubMed]
  29. Yamagata K. Do coffee polyphenols have a preventive action on metabolic syndrome associated endothelial dysfunctions? An assessment of the current evidence. Antioxidants (Basel). 2018;7(2). [Crossref]
  30. Andújar I, Recio MC, Giner RM, Ríos JL. Cocoa polyphenols and their potential benefits for human health. Oxid Med Cell Longev. 2012;2012:906252. [Crossref] [PubMed] [PMC]
  31. Działo M, Mierziak J, Korzun U, Preisner M, Szopa J, Kulma A. The potential of plant phenolics in prevention and therapy of skin disorders. Int J Mol Sci. 2016;17(2):160. [Crossref] [PubMed] [PMC]
  32. Barrea L, Muscogiuri G, Di Somma C, Annunziata G, Megna M, Falco A, et al. Coffee consumption, metabolic syndrome and clinical severity of psoriasis: good or bad stuff? Arch Toxicol. 2018;92(5):1831-45. [Crossref] [PubMed]
  33. Sharif K, Watad A, Bragazzi NL, Adawi M, Amital H, Shoenfeld Y. Coffee and autoimmunity: more than a mere hot beverage! Autoimmun Rev. 2017;16(7):712-21. [Crossref]
  34. Clatici VG, Satolli F, Tatu AL, Voicu C, Draganita AMV, Lotti T. Butterfly effect-the concept and the ımplications in dermatology, acne, and rosacea. Maedica (Buchar). 2018;13(2):89-94.
  35. Steinhoff M, Buddenkotte J, Aubert J, Sulk M, Novak P, Schwab VD, et al. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc. 2011;15(1):2-11. [Crossref] [PubMed] [PMC]
  36. Yuan X, Huang X, Wang B, Huang YX, Zhang YY, Tang Y, et al. Relationship between rosacea and dietary factors: a multicenter retrospective casecontrol survey. J Dermatol. 2019;46(3):219-25. [Crossref] [PubMed]
  37. Li S, Chen ML, Drucker AM, Cho E, Geng H, Qureshi AA, et al. Association of caffeine intake and caffeinated coffee consumption with risk of incident rosacea in women. JAMA Dermatol. 2018;154(12):1394-400. [Crossref] [PubMed]
  38. Echeverri D, Montes FR, Cabrera M, Galán A, Prieto A. Caffeine?s vascular mechanisms of action. Int J Vasc Med. 2010;2010(1):834060. [Crossref]
  39. Schwab VD, Sulk M, Seeliger S, Nowak P, Aubert J, Mess C, et al. Neurovascular and neuroimmune aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc. 2011;15(1):53-62. [Crossref] [PubMed] [PMC]
  40. Ahn CS, Huang WW. Rosacea pathogenesis. Dermatol Clin. 2018;36(2):81-6. [Crossref] [PubMed]

.: Up To Date

.: Process List

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com